Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Senti Biosciences, Inc. | Director | Stock Option (Right to Buy) | 62.5K | Jul 10, 2024 | Direct | ||
Lexeo Therapeutics, Inc. | Director | Stock Option (right to buy) | 18K | Jun 25, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
SNTI | Senti Biosciences, Inc. | Jul 10, 2024 | 1 | $0 | 4 | Jul 12, 2024 | Director |
LXEO | Lexeo Therapeutics, Inc. | Jun 25, 2024 | 1 | $0 | 4 | Jun 27, 2024 | Director |
LXEO | Lexeo Therapeutics, Inc. | Nov 2, 2023 | 0 | $0 | 3 | Nov 2, 2023 | Director |
SNTI | Senti Biosciences, Inc. | Jun 16, 2023 | 1 | $0 | 4 | Jun 21, 2023 | Director |
SNTI | Senti Biosciences, Inc. | Jul 13, 2022 | 1 | $0 | 4 | Jul 15, 2022 | Director |
SNTI | Senti Biosciences, Inc.\ | Jun 8, 2022 | 0 | $0 | 3 | Jun 15, 2022 | Director |